Cytomegalovirus infection post allogeneic allogeneic HLA-identical familial PHT research hub

PILOT ANTI-CMV CLINICAL TRIAL: PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION IN HLA-IDENTICAL FAMILIAL ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH ADVANCED CELLULAR IMMUNOTHERAPY IN PATIENTS WITHOUT SPECIFIC PHARMACOLOGYCAL PROPHYLAXIS AVAILABLE

This study looks at a new way to prevent a common virus called CMV after a stem cell transplant from a family member. We want to see how well this new approach works to stop the virus from becoming active in people who don't have other specific preventative medicines available.